Osman, Keren
44  results:
Search for persons X
?
1

Phase 1 study combining elotuzumab with autologous stem cel..:

Coffey, David G ; Osman, Keren ; Aleman, Adolfo...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008110 , 2024
 
?
2

Characterization of Infectious Complications during the Exp..:

Mihalyova, Jana ; Ahmad, Sana ; Handa, Shivani...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S181 , 2024
 
?
3

CAR T Cell Therapy for Post-Transplant Lymphoproliferative ..:

Ibrahim, Uroosa ; Bassil, Claude ; Chavez, Julio C...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  10 - p. 772-778 , 2023
 
?
7

Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Rand..:

Elsawy, Mahmoud ; Chavez, Julio C. ; Avivi, Irit...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S190-S191 , 2022
 
?
10

Safety, Efficacy, and Outcomes of CD19 CAR T Cell Therapy i..:

Liu, Jieqi ; Narendranath, Epperla ; Ghobadi, Armin...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S205-S206 , 2022
 
?
 
?
13

Cytopenias Following CAR-T Cell Therapy - a Single Center E..:

Ibrahim, Uroosa ; Osman, Keren
Biology of Blood and Marrow Transplantation.  26 (2020)  3 - p. S260 , 2020
 
?
14

A phase 1/2 study to assess safety and dose of ixazomib in ..:

Sanchez, Larysa ; Landau, Heather ; Rosenbaum, Cara...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e330-e331 , 2019
 
?
15

Phase 1 Study of Elotuzumab in Combination with Autologous ..:

Osman, Keren ; Chari, Ajai ; Parekh, Samir Sunil...
Biology of Blood and Marrow Transplantation.  24 (2018)  3 - p. S49-S50 , 2018
 
1-15